Showing results (91-100 of 142) with videos related to
Sort By:
Pageof 15
Internal Medicine (Tokyo, Japan)|April 8, 2026
A Case of Autoimmune Polyendocrine Syndrome Type 3C with Warm-type Autoimmune Hemolytic Anemia which Developed during Treatment for Hashimoto's ThyroiditisYuichiro Iwamoto, Masahiro Komi, Yoshiro Fushimi, et al.Frontiers in Endocrinology|October 29, 2021
Case Report: A Variety of Immune-Related Adverse Events Triggered by Immune Checkpoint Inhibitors in a Subject With Malignant Melanoma: Destructive Thyroiditis, Aseptic Meningitis and Isolated ACTH DeficiencyYukino Katakura, Tomohiko Kimura, Takashi Kusano, et al.Cureus|June 23, 2025
Clinical Characteristics and Hypokalemia Risk Prediction in Patients With Hyperosmolar Hyperglycemic State and Diabetic Ketoacidosis (HHS-DKA): A Single-Center, Retrospective Observational StudyYuichiro Iwamoto, Tomohiko Kimura, Yuichi Morimoto, et al.Internal Medicine (Tokyo, Japan)|August 28, 2024
Nilotinib-induced Diabetes in Japanese Patients with Chronic Myeloid LeukemiaYuichiro Iwamoto, Tomohiko Kimura, Hideyuki Iwamoto, et al.Diabetes & Metabolic Syndrome|July 2, 2026
Association between grip strength and the diabetes complications severity index (DCSI) in patients with type 2 diabetes mellitusHideyuki Iwamoto, Yuichiro Iwamoto, Tomohiko Kimura, et al.Journal of Diabetes Research|June 20, 2017
Inadequate Triglyceride Management Worsens the Durability of Dipeptidyl Peptidase-4 Inhibitor in Subjects with Type 2 Diabetes MellitusMasashi Shimoda, Maiko Miyoshi-Takai, Shintaro Irie, et al.Endocrine Journal|June 16, 2015
Anti-hypertensive azelnidipine preserves insulin signaling and glucose uptake against oxidative stress in 3T3-L1 adipocytesFuminori Tatsumi, Hideaki Kaneto, Mitsuru Hashiramoto, et al.Diabetes, Obesity & Metabolism|June 7, 2018
Protective effects of the SGLT2 inhibitor luseogliflozin on pancreatic β-cells in db/db mice: The earlier and longer, the betterTomohiko Kimura, Atsushi Obata, Masashi Shimoda, et al.Springerplus|September 22, 2016
Strawberry milk-like blood in a subject with diabetic lipemia: dramatic change to transparent color after insulin therapyAtsushi Obata, Shinji Kamei, Seizo Okauchi, et al.Frontiers in Endocrinology|August 16, 2023
Immune checkpoint inhibitor-induced hypothyroidism predicts treatment response in Japanese subjectsYuichiro Iwamoto, Tomohiko Kimura, Kazunori Dan, et al.Pageof 15